{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T15:23:44Z","timestamp":1771946624381,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Board of Physiotherapists"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-95328-9","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T13:47:42Z","timestamp":1743256062000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Functional and structural analysis of SITTER patients with spinal muscular atrophy"],"prefix":"10.1038","volume":"15","author":[{"given":"Aleksandra","family":"Bieniaszewska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Sobieska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Gajewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"key":"95328_CR1","doi-asserted-by":"publisher","first-page":"14873","DOI":"10.3390\/ijms241914873","volume":"24","author":"I Angilletta","year":"2023","unstructured":"Angilletta, I. et al. Spinal muscular atrophy: An evolving scenario through new perspectives in diagnosis and advances in therapies. Int. J. Mol. Sci. 24, 14873. https:\/\/doi.org\/10.3390\/ijms241914873 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"95328_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12883-024-03562-x","volume":"24","author":"B Bjelica","year":"2024","unstructured":"Bjelica, B. et al. Risdiplam therapy in adults with 5q-SMA: observational study on motor function and treatment satisfaction. BMC Neurol. 24, 67. https:\/\/doi.org\/10.1186\/s12883-024-03562-x (2024).","journal-title":"BMC Neurol."},{"key":"95328_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/phar.2866","volume":"44","author":"C Pascual-Morena","year":"2024","unstructured":"Pascual-Morena, C. et al. Efficacy of risdiplam in spinal muscular atrophy: A systematic review and meta-analysis. Pharmacother. J. Hum. Pharmacol. Drug Ther. 44, 97\u2013105. https:\/\/doi.org\/10.1002\/phar.2866 (2024).","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"95328_CR4","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1007\/s00431-023-04883-8","volume":"182","author":"L Antonaci","year":"2023","unstructured":"Antonaci, L., Pera, M. C. & Mercuri, E. New therapies for spinal muscular atrophy: Where we stand and what is next. Eur. J. Pediatr. 182, 2935\u20132942. https:\/\/doi.org\/10.1007\/s00431-023-04883-8 (2023).","journal-title":"Eur. J. Pediatr."},{"key":"95328_CR5","doi-asserted-by":"publisher","unstructured":"Day, J. W. et al. Advances and limitations for the treatment of spinal muscular atrophy. BMC Pediatr. 632, https:\/\/doi.org\/10.1186\/s12887-022-03671-x (2022).","DOI":"10.1186\/s12887-022-03671-x"},{"key":"95328_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JND-190424","volume":"7","author":"DC Schorling","year":"2020","unstructured":"Schorling, D. C., Pechmann, A. & Kirschner, J. Advances in treatment of spinal muscular atrophy: New phenotypes, new challenges, new implications for care. J. Neuromuscul. Dis. 7, 1\u201313. https:\/\/doi.org\/10.3233\/JND-190424 (2020).","journal-title":"J. Neuromuscul. Dis."},{"key":"95328_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpn.2022.04.006","volume":"39","author":"J Erdos","year":"2022","unstructured":"Erdos, J. & Wild, C. Mid- and long-term (at least 12 months) follow-up of patients with spinal muscular atrophy (SMA) treated with nusinersen, onasemnogene abeparvovec, risdiplam or combination therapies: A systematic review of real-world study data. Eur. J. Paediatr. Neurol. 39, 1\u201310. https:\/\/doi.org\/10.1016\/j.ejpn.2022.04.006 (2022).","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"95328_CR8","unstructured":"SMA Fundation in Poland, Available online: https:\/\/www.fsma.pl\/rdzeniowy-zanik-miesni\/diagnostyka\/badania-przesiewowe\/. Accessed on 8 Oct 2024."},{"key":"95328_CR9","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1212\/WNL.0000000000002445","volume":"86","author":"CA Chiriboga","year":"2016","unstructured":"Chiriboga, C. A. et al. Results from a phase 1 study of nusinersen (ISIS-SMNRx ) in children with spinal muscular atrophy. Neurology 86, 890\u2013897. https:\/\/doi.org\/10.1212\/WNL.0000000000002445 (2016).","journal-title":"Neurology"},{"key":"95328_CR10","doi-asserted-by":"publisher","first-page":"e2492","DOI":"10.1212\/WNL.0000000000007527","volume":"92","author":"BT Darras","year":"2019","unstructured":"Darras, B. T. et al. Nusinersen in later-onset spinal muscular atrophy: Long-term results from the phase 1\/2 studies. Neurology 92, e2492\u2013e2506. https:\/\/doi.org\/10.1212\/WNL.0000000000007527 (2019).","journal-title":"Neurology"},{"key":"95328_CR11","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1007\/s40265-020-01410-z","volume":"80","author":"S Dhillon","year":"2020","unstructured":"Dhillon, S. Risdiplam: First approval. Drugs 80, 1853\u20131858. https:\/\/doi.org\/10.1007\/s40265-020-01410-z (2020).","journal-title":"Drugs"},{"key":"95328_CR12","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1177\/1060028020914274","volume":"54","author":"D Stevens","year":"2020","unstructured":"Stevens, D., Claborn, M. K., Gildon, B. L., Kessler, T. L. & Walker, C. Onasemnogene Abeparvovec-xioi: Gene therapy for spinal muscular atrophy. Ann. Pharmacother. 54, 1001\u20131009. https:\/\/doi.org\/10.1177\/1060028020914274 (2020).","journal-title":"Ann. Pharmacother."},{"key":"95328_CR13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/ppul.25142","volume":"56","author":"M G\u00f3mez Garc\u00eda De La-Banda","year":"2021","unstructured":"G\u00f3mez Garc\u00eda De La-Banda, M. et al. Assessment of respiratory muscles and motor function in children with SMA treated by nusinersen. Pediatr. Pulmonol. 56, 299\u2013306. https:\/\/doi.org\/10.1002\/ppul.25142 (2021).","journal-title":"Pediatr. Pulmonol."},{"key":"95328_CR14","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.nmd.2021.02.011","volume":"31","author":"J Trenkle","year":"2021","unstructured":"Trenkle, J., Brugman, J., Peterson, A., Roback, K. & Krosschell, K. J. Filling the gaps in knowledge translation: Physical therapy recommendations for individuals with spinal muscular atrophy compared to standard of care guidelines. Neuromuscul. Disord. 31, 397\u2013408. https:\/\/doi.org\/10.1016\/j.nmd.2021.02.011 (2021).","journal-title":"Neuromuscul. Disord."},{"key":"95328_CR15","doi-asserted-by":"publisher","first-page":"e0201004","DOI":"10.1371\/journal.pone.0201004","volume":"13","author":"A Chabanon","year":"2018","unstructured":"Chabanon, A. et al. Prospective and longitudinal natural history study of patients with Type 2 and 3 spinal muscular atrophy: Baseline data NatHis-SMA study. PLoS ONE 13, e0201004. https:\/\/doi.org\/10.1371\/journal.pone.0201004 (2018).","journal-title":"PLoS ONE"},{"key":"95328_CR16","unstructured":"Syga \u0141., Proga K., Kie\u0142czewski T. Do\u015bwiadczenia pacjent\u00f3w z SMA z leczenia nusinersenem Satysfakcja z leczenia i poprawa jako\u015bci \u017cycia pacjent\u00f3w, PEX, Fundacja SMA, Warszawa (2024)."},{"key":"95328_CR17","doi-asserted-by":"publisher","first-page":"6004","DOI":"10.1007\/s00415-024-12567-y","volume":"271","author":"N Wang","year":"2024","unstructured":"Wang, N. et al. Long-term impact of nusinersen on motor and electrophysiological outcomes in adolescent and adult spinal muscular atrophy: Insights from a multicenter retrospective study. J. Neurol. 271, 6004\u20136014. https:\/\/doi.org\/10.1007\/s00415-024-12567-y (2024).","journal-title":"J. Neurol."},{"key":"95328_CR18","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1177\/18632521241235028","volume":"18","author":"NE Yasar","year":"2024","unstructured":"Yasar, N. E. et al. Nusinersen therapy changed the natural course of spinal muscular atrophy type 1: What about spine and hip?. J. Child. Orthop. 18, 322\u2013330. https:\/\/doi.org\/10.1177\/18632521241235028 (2024).","journal-title":"J. Child. Orthop."},{"key":"95328_CR19","doi-asserted-by":"publisher","unstructured":"Kutlut\u00fcrk-Yikilmaz, S., \u00c7evi\u0307K-Saldiran, T., \u00d6zt\u00fcrk, \u00d6., \u00d6ktem, S. Casting light on mechanical properties of lower and upper extremity muscles in children with spinal muscular atrophy and healthy peers. Arch Health Sci. Res. 11, 91\u201396. https:\/\/doi.org\/10.5152\/ArcHealthSciRes.2024.23089 (2024).","DOI":"10.5152\/ArcHealthSciRes.2024.23089"},{"key":"95328_CR20","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/mus.25430","volume":"55","author":"ES Mazzone","year":"2017","unstructured":"Mazzone, E. S. et al. Revised upper limb module for spinal muscular atrophy: Development of a new module. Muscle Nerve 55, 869\u2013874. https:\/\/doi.org\/10.1002\/mus.25430 (2017).","journal-title":"Muscle Nerve"},{"key":"95328_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/s1090-3798(03)00060-6","volume":"7","author":"M Main","year":"2003","unstructured":"Main, M., Kairon, H., Mercuri, E. & Muntoni, F. The hammersmith functional motor scale for children with spinal muscular atrophy: A scale to test ability and monitor progress in children with limited ambulation. Eur. J. Paediatr. Neurol. 7, 155\u2013159. https:\/\/doi.org\/10.1016\/s1090-3798(03)00060-6 (2003).","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"95328_CR22","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.nmd.2007.05.009","volume":"17","author":"JM O\u2019Hagen","year":"2007","unstructured":"O\u2019Hagen, J. M. et al. An expanded version of the hammersmith functional motor scale for SMA II and III patients. Neuromuscul. Disord. 17, 693\u2013697. https:\/\/doi.org\/10.1016\/j.nmd.2007.05.009 (2007).","journal-title":"Neuromuscul. Disord."},{"key":"95328_CR23","doi-asserted-by":"publisher","first-page":"4232","DOI":"10.3390\/jcm13144232","volume":"13","author":"A Bieniaszewska","year":"2024","unstructured":"Bieniaszewska, A., Sobieska, M. & Gajewska, E. Functional and structural changes in patients with spinal muscular atrophy treated in poland during 12-month follow-up: A prospective cohort study. J. Clin. Med. 13, 4232. https:\/\/doi.org\/10.3390\/jcm13144232 (2024).","journal-title":"J. Clin. Med."},{"key":"95328_CR24","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3390\/biomedicines11041005","volume":"11","author":"A Bieniaszewska","year":"2023","unstructured":"Bieniaszewska, A., Sobieska, M., Steinborn, B. & Gajewska, E. Examination of upper limb function and the relationship with gross motor functional and structural parameters in patients with spinal muscular atrophy. Biomedicines 11, 1005. https:\/\/doi.org\/10.3390\/biomedicines11041005 (2023).","journal-title":"Biomedicines"},{"key":"95328_CR25","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1111\/ene.14472","volume":"27","author":"B Stolte","year":"2020","unstructured":"Stolte, B. et al. Minimal clinically important differences in functional motor scores in adults with spinal muscular atrophy. Eur. J. Neurol. 27, 2586\u20132594. https:\/\/doi.org\/10.1111\/ene.14472 (2020).","journal-title":"Eur. J. Neurol."},{"key":"95328_CR26","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s13311-022-01200-3","volume":"19","author":"M Gavriilaki","year":"2022","unstructured":"Gavriilaki, M. et al. Nusinersen in adults with 5q spinal muscular atrophy: A systematic review and meta-analysis. Neurotherapeutics 19, 464\u2013475. https:\/\/doi.org\/10.1007\/s13311-022-01200-3 (2022).","journal-title":"Neurotherapeutics"},{"key":"95328_CR27","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.3390\/biomedicines10123187","volume":"10","author":"A Bieniaszewska","year":"2022","unstructured":"Bieniaszewska, A., Sobieska, M. & Gajewska, E. Prospective analysis of functional and structural changes in patients with spinal muscular atrophy: A pilot study. Biomedicines 10, 3187. https:\/\/doi.org\/10.3390\/biomedicines10123187 (2022).","journal-title":"Biomedicines"},{"key":"95328_CR28","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1186\/s12891-020-03710-7","volume":"21","author":"A St\u0119pie\u0144","year":"2020","unstructured":"St\u0119pie\u0144, A., Mazurkiewicz, \u0141, Ma\u015blanko, K., Rekowski, W. & J\u0119drzejowska, M. Cervical rotation, chest deformity and pelvic obliquity in patients with spinal muscular atrophy. BMC Musculoskelet. Disord. 21, 726. https:\/\/doi.org\/10.1186\/s12891-020-03710-7 (2020).","journal-title":"BMC Musculoskelet. Disord."},{"key":"95328_CR29","doi-asserted-by":"publisher","first-page":"9134","DOI":"10.3390\/ijerph18179134","volume":"18","author":"A St\u0119pie\u0144","year":"2021","unstructured":"St\u0119pie\u0144, A., Gajewska, E. & Rekowski, W. Motor function of children with SMA1 and SMA2 depends on the neck and trunk muscle strength, deformation of the spine, and the range of motion in the limb joints. Int. J. Environ. Res. Public. Health 18, 9134. https:\/\/doi.org\/10.3390\/ijerph18179134 (2021).","journal-title":"Int. J. Environ. Res. Public. Health"},{"key":"95328_CR30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12891-018-2389-8","volume":"20","author":"A St\u0119pie\u0144","year":"2019","unstructured":"St\u0119pie\u0144, A., J\u0119drzejowska, M., Guzek, K., Rekowski, W. & St\u0119powska, J. Reliability of four tests to assess body posture and the range of selected movements in individuals with spinal muscular atrophy. BMC Musculoskelet. Disord. 20, 54. https:\/\/doi.org\/10.1186\/s12891-018-2389-8 (2019).","journal-title":"BMC Musculoskelet. Disord."},{"key":"95328_CR31","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.3390\/brainsci13101419","volume":"13","author":"Y Qiao","year":"2023","unstructured":"Qiao, Y., Chi, Y., Gu, J. & Ma, Y. Safety and efficacy of nusinersen and risdiplam for spinal muscular atrophy: A systematic review and meta-analysis of randomized controlled trials. Brain Sci. 13, 1419. https:\/\/doi.org\/10.3390\/brainsci13101419 (2023).","journal-title":"Brain Sci."},{"key":"95328_CR32","doi-asserted-by":"publisher","unstructured":"Aponte Ribero, V. et al. Systematic literature review of the natural history of spinal muscular atrophy: Motor function, scoliosis, and contractures. Neurology 101. https:\/\/doi.org\/10.1212\/WNL.0000000000207878 (2023).","DOI":"10.1212\/WNL.0000000000207878"},{"key":"95328_CR33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.nmd.2024.05.003","volume":"41","author":"G Coratti","year":"2024","unstructured":"Coratti, G. et al. Changes in abilities over the initial 12 months of nusinersen treatment for type II SMA. Neuromuscul. Disord. 41, 42\u201350 (2024).","journal-title":"Neuromuscul. Disord."},{"key":"95328_CR34","doi-asserted-by":"publisher","unstructured":"Coratti, G. et al. Early treatment of type II SMA slows rate of progression of scoliosis. J. Neurol. Neurosurg. Psychiatry jnnp-2023\u2013332084, https:\/\/doi.org\/10.1016\/j.nmd.2024.05.003 (2023)","DOI":"10.1016\/j.nmd.2024.05.003"},{"key":"95328_CR35","doi-asserted-by":"publisher","first-page":"948","DOI":"10.29271\/jcpsp.2024.08.948","volume":"34","author":"B Chen","year":"2024","unstructured":"Chen, B., Gong, Y. & Zhou, Y. The impact of nusinersen and risdiplam on motor function for spinal muscular atrophy type 2 and 3: A meta-analysis. J. Coll. Physicians Surg. Pak. 34, 948\u2013955. https:\/\/doi.org\/10.29271\/jcpsp.2024.08.948 (2024).","journal-title":"J. Coll. Physicians Surg. Pak."},{"key":"95328_CR36","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1080\/09638288.2023.2227953","volume":"46","author":"ILB Oude Lansink","year":"2024","unstructured":"Oude Lansink, I. L. B., Gorter, J. W., Van Der Pol, W. L., Bartels, B. & Beelen, A. Impact of contractures on daily functioning in adolescents with spinal muscular atrophy: A qualitative study. Disabil. Rehabil. 46, 2593\u20132599. https:\/\/doi.org\/10.1080\/09638288.2023.2227953 (2024).","journal-title":"Disabil. Rehabil."},{"key":"95328_CR37","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.apmr.2004.01.043","volume":"85","author":"HY Wang","year":"2004","unstructured":"Wang, H. Y., Ju, Y. H., Chen, S. M., Lo, S. K. & Jong, Y. J. Joint range of motion limitations in children and young adults with spinal muscular atrophy. Arch. Phys. Med. Rehabil. 85, 1689\u20131693. https:\/\/doi.org\/10.1016\/j.apmr.2004.01.043 (2004).","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"95328_CR38","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.nmd.2017.07.005","volume":"27","author":"J Montes","year":"2017","unstructured":"Montes, J. et al. First international workshop on rehabilitation management and clinical outcome measures for spinal muscular atrophy, workshop report. Neuromuscul. Disord. 27, 964\u2013969. https:\/\/doi.org\/10.1016\/j.nmd.2017.07.005 (2017).","journal-title":"Neuromuscul. Disord."},{"key":"95328_CR39","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/PEP.0000000000000515","volume":"30","author":"R Salazar","year":"2018","unstructured":"Salazar, R. et al. Quantitative evaluation of lower extremity joint contractures in spinal muscular atrophy: Implications for motor function. Pediatr. Phys. Ther. 30, 209\u2013215. https:\/\/doi.org\/10.1097\/PEP.0000000000000515 (2018).","journal-title":"Pediatr. Phys. Ther."},{"key":"95328_CR40","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.3390\/jcm13092634","volume":"13","author":"ER Harding","year":"2024","unstructured":"Harding, E. R. et al. Beyond contractures in spinal muscular atrophy: Identifying lower-limb joint hypermobility. J. Clin. Med. 13, 2634. https:\/\/doi.org\/10.3390\/jcm13092634 (2024).","journal-title":"J. Clin. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95328-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95328-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95328-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T13:47:46Z","timestamp":1743256066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95328-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["95328"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-95328-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]},"assertion":[{"value":"6 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted by the Declaration of Helsinki and approved by the bioethics committee (no. 1035\/19 date of approval is 7 November 2019). All participants and their parents gave informed consent to the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10810"}}